AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

TARO PHARMACEUTICAL LTD. Haifa Bay, Israel Drug Maker Gets Nod To Sell Generic Cream.(A)

Investor's Business Daily

| December 02, 2002 | COPYRIGHT 2002 Investor's Business Daily, Inc. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

Byline: KIRK SHINKLE

After a long drought of new government approvals, generic-drug maker Taro Pharmaceuticals Inc. finally has a green light for a new product.

On Nov. 26, the Food and Drug Administration approved its generic version of Ortho-McNeil Pharmaceutical's Spectazole cream, used to treat fungal skin infections. Ortho-McNeil is a unit of Johnson & Johnson.

The same day, Taro raised its number of new drug applications to 17 from 15. About the only bad news was that the FDA also approved rival Fougera's generic version of Spectazole.

"(Taro is) not going to get the economic benefit of being first," said analyst Arnie Ursaner of CJS Securities.

Still, analysts estimate Spectazole might fatten Taro's revenue by $10 million next year and add 15 cents to its per-share earnings.

Not that Taro was struggling. It's one of those companies that seems to pump out quarter after quarter of sparkling financial returns.

Related articles from newspapers, magazines, journals, and more
Taro gets FDA OK for generic version of Ultravate.(Taro Pharmaceutical...
Newspaper article from: Pharma Marketletter August 29, 2005 700+ words
Taro Pharmaceutical Industries has received approval from the US Food and Drug Administration to market a generic equivalent of Bristol...
FDA approves Coreg generic version.(Industry News)
Magazine article from: Pharmaceutical Processing October 1, 2007 700+ words
...Glenmark Pharmaceuticals Limited; Lupin Limited; Mylan Pharmaceuticals Inc.; Ranbaxy Laboratories Ltd.; Sandoz Inc.; Taro Pharmaceutical Industries Ltd.; TEVA Pharmaceuticals USA; Watson Laboratories Inc.; and Zydus Pharmaceuticals USA Inc...
Research and Development Program Fuels Taro's Rapid Growth.
Magazine article from: Chain Drug Review September 27, 1999 700+ words
...ANDAs is estimated by Taro executives to exceed...been a main driver of Taro's growth, with a...fluocinonide ointment (a generic version of Medicis The Dermatology...Nizoral). Since 1996 Taro has been building a...carbamazepine (the generic version of Novartis ...
Warfarin Sodium Introduction a Milestone for Taro.
Magazine article from: Chain Drug Review August 30, 1999 700+ words
...and its finished dosage form Taro is able to provide a highquality...steadily growing market share for Taro's warfarin sodium. "We...has also been marketing a generic version of the product.) "We expect...distribution." One issue Taro expects to avoid with its product...
Taro to Supply Generic Elocon-R-to Clay Park in the U.S.
Press release article from: Business Wire December 23, 2004 700+ words
...Industries Ltd. (Nasdaq: TARO) and its affiliates and subsidiaries ("Taro") announced today that...mometasone cream"), a generic version of Schering-Plough's...product will be manufactured by Taro and distributed by Clay Park...
Taro USA Receives Tentative Approval for Mometasone Furoate Topical Solution,...
Press release article from: Business Wire December 6, 2004 700+ words
...mometasone lotion"). Taro's mometasone lotion is a...inflammatory skin conditions. The Taro product is intended to be marketed as a generic version of Schering-Plough's Elocon...an FDA determination that Taro USA's ANDA submission for...
Taro Receives Tentative Approval for Loratadine Syrup.
Press release article from: Business Wire June 27, 2002 700+ words
Business Editors Taro Pharmaceutical Industries Ltd. (NASDAQ/NMS: TARO) reported today that the Company...Loratadine Syrup 10 mg/10 mL. Taro's Loratadine Syrup 10 mg/10 mL is a generic version of Schering-Plough's antihistamine...
Taro plans O-T-C expansion. (over-the-counter drugs)(Taro Pharmaceuticals USA...
Magazine article from: Chain Drug Review September 27, 1993 700+ words
HAWTHORNE, N.Y. -- Taro Pharmaceuticals USA Inc. has...Administration approval for Taro's clotrimazole topical, a generic version of Schering-Plough Corp...to the marketplace. While Taro's products have primarily...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA